"Executing differently takes courage" (3/5) - Trusting the ground : navigating volatility, growth and partnerships across the EEMEA zone
What do we do when the ground is unstable and information is incomplete? We are told to wait for the right conditions. But what if waiting costs more than acting? The real risk is failing to achieve your purpose.
Welcome to Pharma Minds, Summer Series "Executing differently takes courage". I chose this specific conversation because Marc is the one who speaks best about what execution requires when the context refuses to stabilize. Through his experience, I wanted to explore what it concretely costs to actually do what you said you would do. His answer is very simple: we trust the ground and move forward. It reveals that accepting certain departures, stopping certain projects, and changing directions are the necessary costs of executing with integrity.
Marc Gailhardou (who has since been appointed President Intercontinental Region at MSD) brings this perspective from his role leading the EEMEA zone for MSD, while also serving on the board of the digital health startup The Resilience in Oncology. Tasked with managing a geographical area consisting of 25 percent of the world's population, his impossible context is one of permanent volatility. From maintaining operations across war zones to meeting the demands of emerging economies, he proves that long-term vision requires immediate, bold action.
In this episode, we cover:
◾️Leading Through Volatility : Managing safety, compliance, and operations across the diverse EEMEA region.
◾️The Appetite for the Future : Why high-growth markets embrace bold strategies while mature markets hesitate.
◾️Career as a Marathon : Moving out of your comfort zone, creating options, and knowing when it is time to transition.
◾️Corporate to Startup : Gaining agility, speed, and new perspectives through board roles at organizations like The Resilience in Oncology.
◾️Clarity Over Brutality : Focusing on the task rather than attacking the person to lead with respect.
Execution without stability is rarely comfortable. It demands hard choices and decisive momentum. Clarity wins over caution every time.
👉 How do you balance the need to act with the pressure to wait for better data? Let us know in the comments.
Science creates hope. Reality decides impact.
If you want to follow the whole series, don't forget to subscribe.
-
This episode has been translated with the help of AI tools and edited to align with the editorial direction of this series.
Originally released on: 15/12/2025.
To listen to the original French version of this episode: https://smartlink.ausha.co/pharma-minds/48-why-avoiding-risk-is-the-biggest-threat-to-your-pharma-career.
Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.